Key Points Interested in Compass Pathways PLC Sponsored ADR? Here are five stocks we like better. Compass Pathways remains on ...

USA News Group News Commentary - In biotech, the gap between a promising drug and a commercial success is often bridged by a single thing: the operator who has done it before. Helus Pharma (Nasdaq: ...

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.

On August 5, 2026, India welcomes the Krishan Paksh Saptami and Ashwini Nakshatra. This day is ripe for purposeful endeavors ...

Texas Governor Greg Abbott has directed the PUCT and grid operator ERCOT to conduct a comprehensive audit of every large-load ...

The webinar, "AI and Human Flourishing" will ask how technology can be designed to expand human agency, empathy, and ...

The psychedelic compound in magic mushrooms – psilocybin – can improve the symptoms of severe depression, according to the largest randomised, controlled trial of the therapy carried out to date. The ...

Compass found Zillow listings sold at 98.7% of asking vs 100% for banned homes, but list price is agent set, not a value ...

New syndicated study reveals where boat buyers lose momentum and how manufacturers and dealers can influence purchase ...

Studies show that dietary fiber decreases the risks of heart attack and death after a heart attack. In an analysis using data from both the Nurses’ Health Study and the Health Professionals Follow-up ...

Strict requirements that were designed to weed out speculative data center projects could prevent major industrial projects ...

The brokerage released an analysis of its listings showing that those posted on Zillow sold for 1.3% less than “banned” ...